MetaCap

Alpha Tau Medical (DRTS) vs iRadimed (IRMD)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Alpha Tau Medical (DRTS) has outperformed iRadimed (IRMD) over the past year, gaining 207.7% versus a loss of 9.5%. Over five years, IRMD leads with a +91.6% price change compared with +18.5% for DRTS. Alpha Tau Medical is the larger company by market cap ($1.09 billion vs $1.04 billion), about 1.0 times the size.

iRadimed pays a dividend yielding 0.99%, while Alpha Tau Medical does not currently pay one.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DRTS+207.72%IRMD-9.50%
+322%+146%-30%
Nov 21, 20251 yearNov 20, 2026
DRTS+18.62%IRMD+107.53%
+177%+43%-91%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DRTS versus IRMD key metrics
MetricDRTSIRMD
Share price$11.76$81.02
Market cap$1.09B$1.04B
1-day change+3.93%-0.30%
YTD return+137.47%-16.71%
1-year return+207.72%-9.50%
5-year return+18.50%+91.58%
P/E ratio (TTM)—43.33
Forward P/E—33.25
EPS (TTM)$-1.04$1.87
Dividend yield0.00%0.99%
Annual dividend$0.00$0.80
Revenue (latest FY)—$83.81M
Revenue growth (YoY)—+14.43%
Net income (latest FY)$-42.63M$22.48M
Gross margin—76.75%
Operating margin—31.20%
Net margin—26.82%
52-week high$15.79$107.90
52-week low$3.65$76.35
Distance from 52-week high-25.55%-24.91%
Analyst consensusstrong_buynone
Avg. price target upside+75.24%+45.64%
Average volume591.88K120.89K
Shares outstanding92.48M12.79M
Employees121166
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • DRTS has outperformed IRMD by 217.2 percentage points over the past year.

About Alpha Tau Medical

DRTS stock →

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer. Its Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; and preclinical clinical studies for mouse tumors and human-derived tumors.

Health Care · Medical/Dental Instruments · 121 employees

About iRadimed

IRMD stock →

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device.

Health Care · Medical/Dental Instruments · 166 employees

DRTS vs IRMD FAQ

Which is bigger, Alpha Tau Medical or iRadimed?

Alpha Tau Medical (DRTS) is larger, with a market capitalization of $1.09B compared with $1.04B for iRadimed (IRMD).

Which stock has performed better over the past year, DRTS or IRMD?

DRTS returned +207.72% over the past 12 months, compared with -9.50% for IRMD (price return, excluding dividends). Past performance does not predict future results.

Which pays a higher dividend, Alpha Tau Medical or iRadimed?

iRadimed pays a dividend yielding 0.99%, while Alpha Tau Medical does not currently pay a regular dividend.

Are Alpha Tau Medical and iRadimed in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons